Prognostic value of inflammation-based markers in limited disease small-cell lung cancer (LD-SCLC)

被引：0
|
作者：
Kaesmann, L. [1 ]
Bolm, L. [1 ]
Janssen, S. [1 ]
Rades, D. [1 ]
机构：
[1] Univ Lubeck, Dept Radiat Oncol, Lubeck, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2017年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V18-3-jD
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [31] Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
    Pinato, D. J.
    Shiner, R. J.
    Seckl, M. J.
    Stebbing, J.
    Sharma, R.
    Mauri, F. A.
    BRITISH JOURNAL OF CANCER, 2014, 110 (08) : 1930 - 1935
  • [32] Neurologic complications of small-cell lung cancer (SCLC)
    Nasir, SU
    Abrey, LE
    Kris, MG
    Miller, VA
    Dolmau, J
    NEUROLOGY, 2000, 54 (07) : A39 - A39
  • [33] Intensified treatment might improve survival in small cell lung cancer (SCLC) limited disease (LD). The STING study
    Brodin, O.
    Wagenius, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Surgery in limited-disease small-cell lung cancer
    Koul, Parvaiz A.
    LUNG INDIA, 2012, 29 (01) : 2 - 3
  • [35] Chemoradiotherapy in limited-disease small-cell lung cancer
    Fukuda, Minoru
    Ogawara, Daiki
    Nakamura, Yoichi
    Kohno, Shigeru
    LUNG CANCER MANAGEMENT, 2012, 1 (02) : 135 - 143
  • [36] Limited small-cell lung cancer: A potentially curable disease
    Hansen, HH
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 1404 - +
  • [37] Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
    Jae Min Lee
    Hong Sik Lee
    Jong Jin Hyun
    Hyuk Soon Choi
    Eun Sun Kim
    Bora Keum
    Yeon Seok Seo
    Yoon Tae Jeen
    Hoon Jai Chun
    Soon Ho Um
    Chang Duck Kim
    World Journal of Gastrointestinal Oncology, 2016, (07) : 555 - 562
  • [38] The prognostic role of Neutrophil-to-lymphocyte ratio in limited disease small-cell lung cancer
    Kaesmann, L.
    Bolm, L.
    Motisi, L.
    Janssen, S.
    Schild, S. E.
    Rades, D.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S652 - S652
  • [39] PROGNOSTIC FACTORS IN SET OF LIMITED DISEASE SMALL-CELL LUNG CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY
    Zemanova, Milada
    Petruzelka, Lubos
    Honova, Hana
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1346 - S1347
  • [40] Randomized comparison of early vs late twice-daily chest irradiation concurrently with chemotherapy in limited disease small-cell lung cancer (LD,SCLC)
    Samantas, E
    Fountzilas, G
    Panoussaki, E
    Briasoulis, E
    Pavlidis, N
    Kalofonos, G
    Kardamakis, D
    Tsiakopoulos, E
    Palamidas, F
    Skarlos, D
    ANNALS OF ONCOLOGY, 1998, 9 : 84 - 84
12345